SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Nomura Downgrades Deciphera Pharmaceuticals to Neutral, Lowers Price Target to $60

Nomura downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Buy to Neutral and lowers the price target from $84 to $60.

Benzinga · 05/07/2020 09:09

Nomura downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Buy to Neutral and lowers the price target from $84 to $60.